Stock INDSWFTLTD IND-SWIFT LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ind-Swift Limited

Equities

INDSWFTLTD

INE788B01028

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:53 2024-06-07 EDT 		5-day change 1st Jan Change
20.55 INR -0.15% Intraday chart for Ind-Swift Limited -3.25% +14.93%
05-14 Ind-Swift Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
05-14 Ind-Swift Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 391.1 296.3 124.6 246.4 606.1 391.1
Enterprise Value (EV) 1 10,766 10,198 10,127 10,184 10,803 10,186
P/E ratio -0.78 x 5.13 x -0.65 x -0.83 x -3.02 x 1.5 x
Yield - - - - - -
Capitalization / Revenue 0.14 x 0.1 x 0.04 x 0.07 x 0.15 x 0.1 x
EV / Revenue 3.94 x 3.45 x 3.01 x 2.83 x 2.69 x 2.48 x
EV / EBITDA 66.9 x 43.7 x 29.5 x 22.7 x 18.1 x 23 x
EV / FCF 41.7 x 21.6 x -164 x 91 x -52.7 x -59.1 x
FCF Yield 2.4% 4.62% -0.61% 1.1% -1.9% -1.69%
Price to Book -0.06 x -0.04 x -0.02 x -0.04 x -0.08 x -0.06 x
Nbr of stocks (in thousands) 54,165 54,165 54,165 54,165 54,165 54,165
Reference price 2 7.220 5.470 2.300 4.550 11.19 7.220
Announcement Date 18-08-14 19-08-21 20-09-08 21-09-07 22-08-26 23-09-05
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 2,733 2,952 3,369 3,597 4,018 4,110
EBITDA 1 160.8 233.6 343.6 449.4 597.4 443.2
EBIT 1 -165.6 -86.24 27.77 142.6 297.5 160.2
Operating Margin -6.06% -2.92% 0.82% 3.96% 7.4% 3.9%
Earnings before Tax (EBT) 1 -496.8 57.71 -166.6 -294.9 -196 260.4
Net income 1 -504.3 57.71 -191.2 -298.2 -200.2 260.4
Net margin -18.45% 1.96% -5.68% -8.29% -4.98% 6.34%
EPS 2 -9.310 1.066 -3.530 -5.505 -3.700 4.807
Free Cash Flow 1 258.4 471.1 -61.83 111.9 -205 -172.4
FCF margin 9.46% 15.96% -1.84% 3.11% -5.1% -4.2%
FCF Conversion (EBITDA) 160.69% 201.66% - 24.9% - -
FCF Conversion (Net income) - 816.19% - - - -
Dividend per Share - - - - - -
Announcement Date 18-08-14 19-08-21 20-09-08 21-09-07 22-08-26 23-09-05
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 10,375 9,902 10,002 9,938 10,197 9,795
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 64.5 x 42.39 x 29.11 x 22.11 x 17.07 x 22.1 x
Free Cash Flow 1 258 471 -61.8 112 -205 -172
ROE (net income / shareholders' equity) 7.89% -0.86% 2.75% 4.23% 2.83% -3.65%
ROA (Net income/ Total Assets) -1.62% -0.89% 0.29% 1.4% 2.85% 1.56%
Assets 1 31,172 -6,495 -66,117 -21,299 -7,017 16,659
Book Value Per Share 2 -125.0 -125.0 -132.0 -128.0 -133.0 -130.0
Cash Flow per Share 2 0.6800 3.640 3.090 5.350 2.990 2.460
Capex 1 61.6 140 126 202 196 308
Capex / Sales 2.25% 4.75% 3.75% 5.62% 4.87% 7.5%
Announcement Date 18-08-14 19-08-21 20-09-08 21-09-07 22-08-26 23-09-05
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
IND-SWIFT LIMITED Stock Ind-Swift Limited
+14.93% 13.33M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 765B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 632B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.32% 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 248B
NOVARTIS AG Stock Novartis AG
+11.88% 216B
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 219B
AMGEN INC. Stock Amgen Inc.
+5.90% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. INDSWFTLTD Stock
  4. Financials Ind-Swift Limited